Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
61
2025
3050
4.120
Why?
Antibodies, Bispecific
6
2025
94
1.140
Why?
Hematopoietic Stem Cell Transplantation
8
2024
606
0.890
Why?
Leukemia, Plasma Cell
2
2020
33
0.830
Why?
Plasma Cells
7
2025
239
0.770
Why?
Immunotherapy, Adoptive
5
2024
167
0.690
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
125
0.670
Why?
Bone Marrow
10
2022
363
0.670
Why?
B-Cell Maturation Antigen
7
2025
98
0.670
Why?
Neoplasms, Plasma Cell
3
2024
37
0.620
Why?
Humans
70
2025
52593
0.580
Why?
Chromosome Deletion
2
2023
141
0.560
Why?
Gene Expression Profiling
11
2025
1110
0.550
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.540
Why?
Diffusion Magnetic Resonance Imaging
4
2025
133
0.540
Why?
Positron-Emission Tomography
5
2025
303
0.540
Why?
Neoplasm, Residual
7
2025
173
0.530
Why?
Prognosis
17
2025
2118
0.510
Why?
Tumor Suppressor Protein p53
2
2017
224
0.500
Why?
Clinical Trials as Topic
4
2022
472
0.500
Why?
Transplantation, Autologous
9
2024
488
0.500
Why?
Gene Expression Regulation, Neoplastic
6
2021
857
0.490
Why?
Aged
25
2025
10191
0.470
Why?
Proteasome Inhibitors
1
2016
105
0.470
Why?
Immunologic Factors
1
2016
117
0.460
Why?
Immunotherapy
1
2016
244
0.430
Why?
Translocation, Genetic
5
2021
265
0.420
Why?
Antibodies, Monoclonal
2
2022
478
0.410
Why?
Mutation
7
2022
1344
0.410
Why?
Neoplasm Proteins
4
2020
328
0.380
Why?
Neutropenia
2
2023
115
0.380
Why?
Stem Cell Transplantation
4
2022
187
0.370
Why?
Survival Analysis
8
2024
673
0.370
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.360
Why?
Neoplasms
2
2012
1308
0.360
Why?
Lymphocytes
1
2012
149
0.360
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Cancer Vaccines
1
2011
78
0.340
Why?
Neoplasm Recurrence, Local
7
2024
643
0.330
Why?
Middle Aged
23
2025
13096
0.320
Why?
Aged, 80 and over
10
2025
3420
0.310
Why?
Female
29
2025
28262
0.310
Why?
Cytokines
1
2012
626
0.300
Why?
Tumor Microenvironment
3
2024
255
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1031
0.280
Why?
Hematologic Neoplasms
2
2022
106
0.280
Why?
Male
27
2025
26863
0.270
Why?
Adult
19
2025
14170
0.270
Why?
Combined Modality Therapy
4
2024
639
0.260
Why?
Atrial Fibrillation
2
2022
201
0.260
Why?
Disease Progression
7
2025
873
0.240
Why?
Fluorodeoxyglucose F18
4
2021
188
0.230
Why?
Proto-Oncogene Proteins B-raf
3
2020
80
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Neoplasms, Second Primary
1
2024
77
0.210
Why?
Chromosomes, Human, Pair 1
2
2023
96
0.200
Why?
Paraproteinemias
1
2022
74
0.190
Why?
Risk Factors
9
2024
3952
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Osteolysis
1
2022
75
0.190
Why?
Drug Approval
1
2022
43
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
62
0.180
Why?
Recurrence
6
2024
683
0.180
Why?
Treatment Outcome
7
2022
5486
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Patient Participation
1
2022
69
0.180
Why?
T-Lymphocytes
4
2024
329
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Cell Cycle
1
2021
240
0.170
Why?
Practice Guidelines as Topic
1
2023
496
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Resorption
1
2022
302
0.160
Why?
Bone Diseases
1
2021
95
0.160
Why?
Retrospective Studies
8
2025
6671
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Disease-Free Survival
5
2019
464
0.160
Why?
Antigens, CD
1
2020
216
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Healthcare Disparities
1
2022
300
0.150
Why?
Spleen
1
2019
171
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Bacteremia
1
2019
90
0.140
Why?
Brain Neoplasms
2
2011
290
0.140
Why?
Antineoplastic Agents
2
2024
1221
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Gene Rearrangement
1
2018
76
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Retinoblastoma Binding Proteins
1
2017
11
0.130
Why?
Flow Cytometry
1
2018
400
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Pelvis
1
2017
67
0.130
Why?
Epigenesis, Genetic
1
2020
407
0.130
Why?
Cell Proliferation
4
2023
1029
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
106
0.130
Why?
Survival Rate
4
2020
952
0.130
Why?
Immunoglobulin Light Chains
1
2017
90
0.130
Why?
Clonal Evolution
1
2016
59
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Ubiquitin-Protein Ligases
1
2017
137
0.120
Why?
Gene Expression
1
2018
623
0.120
Why?
Transcriptome
3
2025
368
0.110
Why?
Animals
4
2024
13507
0.110
Why?
Cystatin M
2
2024
19
0.100
Why?
Cross-Sectional Studies
3
2023
1686
0.100
Why?
Cardiovascular Diseases
1
2017
495
0.090
Why?
Follow-Up Studies
3
2024
2291
0.090
Why?
Lymphoma, Non-Hodgkin
1
2011
58
0.090
Why?
Astrocytoma
1
2011
19
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Disease Models, Animal
1
2016
1486
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
263
0.090
Why?
Glioma
1
2011
77
0.080
Why?
Genomics
2
2023
270
0.080
Why?
Alleles
2
2021
278
0.080
Why?
Remission Induction
2
2021
219
0.080
Why?
Tumor Burden
2
2020
136
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
69
0.080
Why?
Histones
2
2021
316
0.080
Why?
Vaccination
1
2011
299
0.080
Why?
Transcription Factors
2
2023
566
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Radiopharmaceuticals
2
2021
205
0.070
Why?
Models, Biological
1
2011
741
0.070
Why?
Cell Differentiation
2
2022
673
0.070
Why?
Kaplan-Meier Estimate
2
2019
485
0.060
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Biopsy
2
2018
607
0.060
Why?
ROC Curve
1
2025
254
0.060
Why?
Arkansas
2
2021
2029
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
115
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
Antibodies
1
2024
150
0.050
Why?
Mice
2
2024
5958
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Signal Transduction
2
2021
1714
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
66
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Patient Selection
1
2023
266
0.050
Why?
United States Food and Drug Administration
1
2022
96
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Bone Marrow Transplantation
1
2022
113
0.050
Why?
Chromosome Aberrations
1
2023
297
0.050
Why?
Dexamethasone
1
2024
440
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Syndecan-1
1
2021
73
0.050
Why?
RANK Ligand
1
2022
187
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Clone Cells
1
2021
76
0.040
Why?
Chromatin
1
2021
141
0.040
Why?
Pyrimidines
1
2022
200
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2022
237
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Protein Kinase Inhibitors
1
2022
228
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Cell Line, Tumor
1
2023
1436
0.040
Why?
Health Status Disparities
1
2022
216
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
179
0.040
Why?
Multivariate Analysis
1
2021
602
0.040
Why?
Computational Biology
1
2020
211
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Syndrome
1
2019
253
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
426
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Oncogene Proteins, Fusion
1
2018
60
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Protein-Tyrosine Kinases
1
2018
89
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
Retinoblastoma Protein
1
2017
19
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Fibroblast Growth Factors
1
2017
47
0.030
Why?
STAT3 Transcription Factor
1
2017
87
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Bone and Bones
1
2021
494
0.030
Why?
Glomerular Filtration Rate
1
2017
130
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Alkaline Phosphatase
1
2017
93
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Sequence Analysis, DNA
1
2017
230
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
NF-kappa B
1
2018
329
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
DNA Methylation
1
2020
592
0.030
Why?
Genomic Instability
1
2016
89
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
Why?
Staphylococcal Infections
1
2019
280
0.030
Why?
Logistic Models
1
2018
934
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
150
0.030
Why?
Melphalan
1
2016
181
0.030
Why?
Heart
1
2017
361
0.030
Why?
Kidney Diseases
1
2017
231
0.030
Why?
Algorithms
1
2018
668
0.030
Why?
Echocardiography
1
2017
416
0.030
Why?
Time Factors
1
2021
3000
0.030
Why?
Thalidomide
1
2016
378
0.030
Why?
Myocardium
1
2017
479
0.030
Why?
Disease Management
1
2015
188
0.030
Why?
Longitudinal Studies
1
2016
747
0.030
Why?
Risk Assessment
1
2018
1350
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1378
0.030
Why?
Ifosfamide
1
2011
9
0.020
Why?
Dacarbazine
1
2011
11
0.020
Why?
Tomography, X-Ray Computed
1
2017
1162
0.020
Why?
Carboplatin
1
2011
57
0.020
Why?
Etoposide
1
2011
71
0.020
Why?
Fatal Outcome
1
2011
196
0.020
Why?
Treatment Failure
1
2011
122
0.020
Why?
United States
1
2022
5227
0.020
Why?
Drug Administration Schedule
1
2011
376
0.020
Why?
Magnetic Resonance Imaging
1
2017
1545
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description